Schedule 13G ownership disclosure

Aquestive Therapeutics Inc

Common Stock · CUSIP: 03843E104

Event date: 2025-09-30

Filing-level shares
6,426,343
Percent of class
5.3%
  • BlackRock, Inc.

    Shares: 6,426,343 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-25-002498
Form type
SCHEDULE 13G/A
Filer
Aquestive Therapeutics, Inc.
CIK
CIK 1398733
Filed
Oct 17, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub